| De novo mutations in epileptic encephalopathies Nature 501 (7466), 217-221, 2013 | 1466* | 2013 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1362 | 2018 |
| The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1016-1026, 2007 | 1137 | 2007 |
| The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1000-1015, 2007 | 1063 | 2007 |
| Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial A Marson, A Jacoby, A Johnson, L Kim, C Gamble, D Chadwick The Lancet 365 (9476), 2007-2013, 2005 | 554 | 2005 |
| Aggregate data meta‐analysis with time‐to‐event outcomes PR Williamson, CT Smith, JL Hutton, AG Marson Statistics in medicine 21 (22), 3337-3351, 2002 | 526 | 2002 |
| The new antiepileptic drugs: a systematic review of their efficacy and tolerability AG Marson, ZA Kadir, JL Hutton, DW Chadwick Epilepsia 38 (8), 859-880, 1997 | 419 | 1997 |
| Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial LG Kim, TL Johnson, AG Marson, DW Chadwick The Lancet Neurology 5 (4), 317-322, 2006 | 401 | 2006 |
| Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child J Weston, R Bromley, CF Jackson, N Adab, J Clayton‐Smith, ... Cochrane database of systematic reviews, 2016 | 399 | 2016 |
| Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child R Bromley, J Weston, N Adab, J Greenhalgh, A Sanniti, AJ McKay, ... Cochrane Database of Systematic Reviews, 2014 | 331 | 2014 |
| De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies S Appenzeller, R Balling, N Barisic, S Baulac, H Caglayan, D Craiu, ... The American Journal of Human Genetics 95 (4), 360-370, 2014 | 316 | 2014 |
| New antiepileptic drugs: a systematic review of their efficacy and tolerability AG Marson, ZA Kadir, DW Chadwick Bmj 313 (7066), 1169-1174, 1996 | 314 | 1996 |
| Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data SJ Nevitt, M Sudell, S Cividini, AG Marson, CT Smith Cochrane Database of Systematic Reviews, 2022 | 291 | 2022 |
| Valproate in the treatment of epilepsy in girls and women of childbearing potential T Tomson, A Marson, P Boon, MP Canevini, A Covanis, E Gaily, ... Epilepsia 56 (7), 1006-1019, 2015 | 274 | 2015 |
| Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and … HJ Lamberink, WM Otte, AT Geerts, M Pavlovic, J Ramos-Lizana, ... The Lancet Neurology 16 (7), 523-531, 2017 | 254 | 2017 |
| De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies CT Myers, JM McMahon, AL Schneider, S Petrovski, AS Allen, GL Carvill, ... The American Journal of Human Genetics 99 (2), 287-298, 2016 | 249 | 2016 |
| Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals YCA Feng, DP Howrigan, LE Abbott, K Tashman, F Cerrato, T Singh, ... The American Journal of Human Genetics 105 (2), 267-282, 2019 | 230 | 2019 |
| Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? J Taylor, R Kolamunnage‐Dona, AG Marson, PEM Smith, AP Aldenkamp, ... Epilepsia 51 (1), 48-56, 2010 | 222 | 2010 |
| Deep brain and cortical stimulation for epilepsy M Sprengers, K Vonck, E Carrette, AG Marson, P Boon Cochrane Database of Systematic Reviews, 2017 | 196 | 2017 |
| Investigating heterogeneity in an individual patient data meta‐analysis of time to event outcomes CT Smith, PR Williamson, AG Marson Statistics in medicine 24 (9), 1307-1319, 2005 | 193 | 2005 |
